Final Program

36 SUNDAY • MAY 15
9:15 Hyperpolarized Xenon-129 MRI: A New Tool to Evaluate
COPD/K. Qing, Y.M. Shim, N.J. Tustison, T.A. Altes, K. Ruppert,
J.F. Mata, B. Mehrad, G.W. Miller, S. Guan, I.C. Ruset, F.W.
Hersman, J.P. Mugler, Charlottesville, VA, p.A1049
9:30 Testing the Fletcher-Peto Assumptions Using Pulmonary
Imaging Biomarker Longitudinal Measurements/R.L. Eddy, D.
Pike, K. Sheikh, G. Paulin, M. Kirby, D.G. McCormack, G. Parraga,
London, Canada, p.A1050
9:45 Prediction of Future Lung Function Decline from Baseline
Hybrid Hyperpolarized 3He MRI in Current Smokers and COPD
Patients/H. Hamedani, S. Kadlecek, Y. Xin, M. Cereda, H. Gatens,
J. Naji, S. Siddiqui, M. Pourfathi, M. Rossman, R.R. Rizi,
Philadelphia, PA, p.A1051
10:00 Regional Ventilation Defects Measured on Hyperpolarized 3He
MRI Are Associated with Mucus Plugging Measured on CT in
Asthma/E. Dunican, J.V. Fahy, D.G. Mummy, S. Fain, E.A.
Hoffman, B.M. Elicker, D.S. Gierada, J.D. Newell, Jr, N.N. Jarjour,
M. Castro, S. Nagle, San Francisco, CA, p.A1052
10:15 Segmental Ventilation Defect Percentage in Hyperpolarized
3He MRI in Asthma Is Associated with Airway Wall Thickness
Measured on CT/D.G. Mummy, W. Zha, R. Sorkness, L.C.
Denlinger, J.D. Quirk, D. Gierada, J.C. Woods, M. Castro, N.N.
Jarjour, S. Fain, Madison, WI, p.A1053
10:30 What Does Magnetic Resonance Imaging Signal-Intensity Mean
in Asthma?/K. Sheikh, F. Guo, S. Svenningsen, A. Ouriadov, D.P.
Capaldi, R.L. Eddy, D.G. McCormack, G. Parraga, London,
Canada, p.A1054
10:45 Measurement of Asthma Treatment Response Using
Free-Breathing 1H Ventilation MRI/D.P. Capaldi, K. Sheikh, S.
Svenningsen, M. Kirby, H. Coxson, D.G. McCormack, G. Parraga,
London, Canada, p.A1055
A21
POSTER DISCUSSION SESSION
CHRONIC AIRWAY INFLAMMATION: MICROBIAL
INFLUENCE
9:00 a.m. - 11:00 a.m. MOSCONE CENTER
Room 2024 (West Building, Level 2)
Poster Viewing 9:00-9:45
Discussion 9:45-11:00
Chairing: J.S. Deshane, PhD, Birmingham, AL
M.R. Stampfli, PhD, Hamilton, Canada
P.S. Foster, PhD, Callaghan, Australia
S. Bozinovski, PhD, Bundoora, Australia
601 The Effects of Smoking on The Lower Airway DNA Virome/B.C.
Keller, G. Zhao, B.G. Wu, J.C. Clemente, L.N. Segal, St. Louis,
MO, p.A1056
602 Longitudinal Changes in Airway Microbiome Signatures and
Immunoregulatory Cell Dynamics Following Bronchial
Thermoplasty/J.S. Deshane, J. Trevor, Y. Wang, D. Zhi, M.
Curtiss, F. Wang, P.G. Eipers, V.D.P. William, C. Morrow, M.T.
Dransfield, Birmingham, AL, p.A1057
603 A Study to Define the Microbiome of the Asthmatic Airway/E.
Hunt, S. Lapthorne, C. Ward, J. Eustace, B. Plant, D. Murphy, J.
MacSharry, Cork, Ireland, p.A1058
604 Nasal Microbiome Composition Varies over Time in Pediatric
Asthma/M. Perez-Losada, L. Alamri, A. Goldstein, K.A. Crandall,
R.J. Freishtat, Ashburn, VA, p.A1059
605 The Infant Gut Microbiome, Respiratory Infection, and
Repeated Wheeze in the First Year of Life: Findings from the
Vitamin D Antenatal Asthma Reduction Trial (VDAART)/J.E.
Sordillo, Y. Zhou, M. McGeachie, N. Lange, N. Laranjo, J. Savage,
V.J. Carey, E. Sodergren, S.T. Weiss, D.R. Gold, G. Weinstock,
A.A. Litonjua, Boston, MA, p.A1060
606 Factors Influencing the Infant Gut Microbiome at Age 3-6
Months: Findings from the Ethnically Diverse Vitamin D
Antenatal Asthma Reduction Trial (VDAART)/J.E. Sordillo, Y.
Zhou, M. McGeachie, N. Lange, N. Laranjo, J. Savage, V.J. Carey,
G. Weinstock, E. Sodergren, D.R. Gold, S.T. Weiss, A.A. Litonjua,
Boston, MA, p.A1061
607 Utilizing the Collaborative Cross Cohort to Identify the
Genetics of Host Responses to Respiratory Syncytial
Virus/A.S. Buntzman, D. Francisco, K. Addison, A. Manne, J.
Frelinger, J.G. Ledford, F.D. Martinez, M. Kraft, Tucson, AZ,
p.A1062
608 Rhinovirus-Induced Production of PGE2 by Asthmatic
Bronchial Epithelial Cells: Inverse Association with Strain
Pathogenicity/L. Shi, E. Roti Roti, A. Guadarrama, P. Fichtinger,
L.C. Denlinger, Madison, WI, p.A1063
609 Group A Streptococcus (GAS) Indudes Bronchial Asthma
(BA)/T. Matsuda, Misato-shi, Saitama, Japan, p.A1064
610 Bronchial Microbiome in Severe Persistent Oral
Corticosteroid-Dependent Asthma/L. Millares, G. Bermudo, M.
Garcia-Nunez, C. Grimau, N. Martinez-Lopez, V. Perez-Brocal, C.
Domingo, E. Monso, Sabadell, Spain, p.A1065
611 Effects of Recombinant Myristoylated Rhinovirus VP4 Protein
on Primary Alveolar Macrophages/J.K. Bentley, S. Jaipalli, M.
Han, J. Lei, M.B. Hershenson, Ann Arbor, MI, p.A1066
612 Mycobiome Analysis of Lower Airway Secretions from
Children with Fungal-Sensitized Severe-Persistent
Asthma/E.M. St. John Sutton, A. Tsuang, S. Viswanathan, R.
Burke, D.L. Goldman, A.G. Vicencio, New York, NY, p.A1067
613 Gene Expression and Protein Secretion in Normal Versus
Diseased Human Lung Tissue/L. Sherman, D. Mohn, K. Miner, C.
Vezina, J.A. Johnston, Thousand Oaks, CA, p.A1068
614 Infants with Early Wheeze Have Decreased Lung Function and
Microbial Changes of Their Upper Airway at 3 Months of Age/K.
Kloepfer, S. Srivatsa, J.E. Hatch, D. Nelson, S. Janga, S.D. Davis,
Indianapolis, IN, p.A1069
ATS 2016 • San Francisco